Tell us about your experience of getting a T3 prescription.
In January 2020 we completed a T3 Prescribing Report, with our partners. This report, on Clinical Commissioning Groups, CCGs in England, will be published on 7th February 2020 and reveals an unfair postcode lottery, for this specialist treatment for hypothyroidism, which we and our partners are working hard to put an end to.
We still want to know about issues patients may be experiencing accessing liothyronine around the UK, not just in England.
If you did not respond to the T3 Prescribing Report. Please use the form below to let us know if you are being told that liothyronine is not available on the NHS in your area.
No personal data is being captured, unless you expressly ask us to keep your contact details on file, so that we can contact you in future.
Please note, if you have not spoken to your doctor recently about the situation, NHS England published updated prescribing guidance in July 2019 which it is worth taking to your doctor and/or talking to your local health authority about, to check if their policy has changed since you were last in touch. NICE have also published a new guideline on the assessment and management of thyroid disease, but this is not intended to be comprehensive and does not say a great deal about liothyronine.
NHS England and the Department of Health have confirmed that if a patient requires liothyronine to manage the symptoms of hypothyroidism, it should be prescribed on the NHS. Treatment with liothyronine should be initiated or reviewed by a specialist. You must be in the UK to participate in this research.
We still want to know about issues patients may be experiencing accessing liothyronine around the UK, not just in England.
If you did not respond to the T3 Prescribing Report. Please use the form below to let us know if you are being told that liothyronine is not available on the NHS in your area.
No personal data is being captured, unless you expressly ask us to keep your contact details on file, so that we can contact you in future.
Please note, if you have not spoken to your doctor recently about the situation, NHS England published updated prescribing guidance in July 2019 which it is worth taking to your doctor and/or talking to your local health authority about, to check if their policy has changed since you were last in touch. NICE have also published a new guideline on the assessment and management of thyroid disease, but this is not intended to be comprehensive and does not say a great deal about liothyronine.
NHS England and the Department of Health have confirmed that if a patient requires liothyronine to manage the symptoms of hypothyroidism, it should be prescribed on the NHS. Treatment with liothyronine should be initiated or reviewed by a specialist. You must be in the UK to participate in this research.
Your privacy is important to us. Read our privacy policy.
